Skip to content

CORMEDIX INC.: 10-Q filed 2014-08-14

What CORMEDIX INC. reported in its quarterly report filed 2014-08-14 (fiscal Q2 2014): 37 published measures, 106 facts as tagged in accession 0001354488-14-004247.

This filing

Form
10-Q (quarterly report)
Filed
2014-08-14
Fiscal period
fiscal Q2 2014
Accession
0001354488-14-004247 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-06-308,255,514USD
At 2013-12-312,967,800USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-06-309,856,294USD
At 2013-12-316,990,143USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-06-30-1,600,780USD
At 2013-12-31-4,022,343USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-06-307,651,844USD
At 2013-12-312,373,893USD
At 2013-06-30158,405USD
At 2012-12-31835,471USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-303,509,290USD91
2014-01-01 to 2014-06-30-13,204,001USD181
2013-04-01 to 2013-06-30-1,950,871USD91
2013-01-01 to 2013-06-30-3,197,923USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-2,935,421USD181
2013-01-01 to 2013-06-30-1,177,066USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-06-3019,613USD181
2013-01-01 to 2013-06-300USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-04-01 to 2014-06-3039,729USD91
2014-01-01 to 2014-06-3051,932USD181
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-06-308,253,416USD181
2013-01-01 to 2013-06-30500,000USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-19,613USD181
2013-01-01 to 2013-06-300USD181

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-04-01 to 2014-06-3021,993,384shares91
2014-01-01 to 2014-06-3020,636,671shares181
2013-04-01 to 2013-06-3013,048,815shares91
2013-01-01 to 2013-06-3012,329,993shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-04-01 to 2014-06-3025,439,799shares91
2014-01-01 to 2014-06-3020,636,671shares181
2013-04-01 to 2013-06-3013,048,815shares91
2013-01-01 to 2013-06-3012,329,993shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-04-01 to 2014-06-300.12USD/shares91
2014-01-01 to 2014-06-30-0.64USD/shares181
2013-04-01 to 2013-06-30-0.15USD/shares91
2013-01-01 to 2013-06-30-0.28USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-0.05USD/shares91
2014-01-01 to 2014-06-30-0.64USD/shares181
2013-04-01 to 2013-06-30-0.15USD/shares91
2013-01-01 to 2013-06-30-0.28USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-06-3054,180USD
At 2013-12-3136,061USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-06-301,775,753USD181
2013-01-01 to 2013-06-30431,849USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-1,889,720USD91
2014-01-01 to 2014-06-30-4,824,270USD181
2013-04-01 to 2013-06-30-1,288,910USD91
2013-01-01 to 2013-06-30-2,095,687USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-06-308,187,992USD
At 2013-12-312,916,031USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-04-01 to 2014-06-30513USD91
2014-01-01 to 2014-06-30978USD181
2013-04-01 to 2013-06-30661,162USD91
2013-01-01 to 2013-06-301,101,565USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-06-301,180,516USD
At 2013-12-311,674,081USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-06-30848,645USD
At 2013-12-31939,785USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,874,970USD91
2014-01-01 to 2014-06-304,740,697USD181
2013-04-01 to 2013-06-301,288,910USD91
2013-01-01 to 2013-06-302,095,687USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-06-30278,049USD
At 2013-12-3180,021USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-14,750USD91
2014-01-01 to 2014-06-30-83,573USD181
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-54,479USD91
2014-01-01 to 2014-06-30-135,505USD181
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,703,041USD91
2014-01-01 to 2014-06-304,215,750USD181
2013-04-01 to 2013-06-30908,736USD91
2013-01-01 to 2013-06-301,460,478USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-04-01 to 2014-06-30171,929USD91
2014-01-01 to 2014-06-30524,947USD181
2013-04-01 to 2013-06-30380,174USD91
2013-01-01 to 2013-06-30635,209USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-06-3021,996,116shares
At 2013-12-3116,606,695shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-06-30-1,340USD
At 2013-12-31-9,323USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-06-30256,151USD
At 2013-12-31713,179USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-06-30203,087USD
At 2013-12-31232,987USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-04-01 to 2014-06-303,518,634USD91
2014-01-01 to 2014-06-30-13,196,018USD181
2013-04-01 to 2013-06-30-1,950,871USD91
2013-01-01 to 2013-06-30-3,197,923USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-302,715,490USD91
2014-01-01 to 2014-06-30-13,258,603USD181
2013-04-01 to 2013-06-30-1,950,871USD91
2013-01-01 to 2013-06-30-3,507,867USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-06-301,112USD181
2013-01-01 to 2013-06-301,086USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-3052,941USD181
2013-01-01 to 2013-06-300USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30198,028USD181
2013-01-01 to 2013-06-300USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-62,660USD181
2013-01-01 to 2013-06-30387,430USD181

Inspect the source

Entity
CORMEDIX INC. / CIK 0001410098
Captured
2026-09-20T08:01:45.168Z
SEC response SHA-256
b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))